Skip to content

Feasibility study Mid-Field (0.6 T) MRI system

Feasibility study Mid-Field (0.6 T) MRI system - Mid-Field MRI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57445
Enrollment
880
Registered
2024-09-27
Start date
2025-03-06
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General cases that require Medical Imaging

Interventions

A prototype 0.6 T MR scanner been developed by Philips, based on a&nbsp
commercially available 1.5 T MR scanner.&nbsp

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients: older than 18 years; Healthy control subjects: age between 18 and 65 years old. 2. Patients: Medical diagnostics requested focused at brain, back, knee, lung, cardiac, (prosthetic joints), whole body MRI or abdomen.

Exclusion criteria

Exclusion criteria: 3. Age <18 years or (only for healthy control subjects) older than 65 years old 4. Persons with reduced mental capacity that would make informed consent  impossible 5. Pregnancy and a chance of being pregnant (as reported by the volunteer or  patient) 6. Not having a general practitioner 7. MRI contraindications (see www.mrisafety.com) or claustrophobia. Decision on  the MRI contraindication is made according to the guidelines outlined in the MR  safety document of the Department of Radiology which can be found in the  attachment (*MRI Veiligheidsrichtlijnen LUMC (BPPC-protocol)*). Subjects  suffering from tinnitus will be warned for the (potential) loud noise of the  scanner and will confirm that they considered the noise level into account when  providing informed consent.

Design outcomes

Primary

MeasureTime frame
We will assess the quality of mid-field MRI in the previously mentioned anatomical regions compared to the routine diagnostic approaches as requested for the patient. This qualitative assessment allows to identify both diagnostical questions that are very feasible to answer as questions that need further technical refinement or will remain high-field MRI in the future. The second endpoint is to provide novel MRI methods specific to mid-field MR to increase the obtained information in limited scan time, to improve patient comfort and to reduce costs related to acquisition and operation of an MRI scanner.

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Contacts

Public ContactM A Nagtegaal

Leids Universitair Medisch Centrum

m.a.nagtegaal@lumc.nl071-5263832

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)